Primary Site >> Pancreatic Cancer
Gene >> IDO1
| 1. | |||||||||||
| Journal: | J Am Coll Surg. 2008 May;206(5):849-54; discussion 854-6. | ||||||||||
| Title: | Expression of indoleamine 2,3-dioxygenase in metastatic pancreatic ductal adenocarcinoma recruits regulatory T cells to avoid immune detection. | ||||||||||
| Author: | Witkiewicz, Agnes|Williams, Timothy K|Cozzitorto, Joseph|Durkan, Brandice|Showalter, Shayna L|Yeo, Charles J|Brody, Jonathan R | ||||||||||
| PMID: | 18471709 | ||||||||||
| 2. | |||||||||||
| Journal: | J Immunol. 2008 Sep 1;181(5):3116-25. | ||||||||||
| Title: | MUC1 enhances tumor progression and contributes toward immunosuppression in a mouse model of spontaneous pancreatic adenocarcinoma. | ||||||||||
| Author: | Tinder, Teresa L|Subramani, Durai B|Basu, Gargi D|Bradley, Judy M|Schettini, Jorge|Million, Arefayene|Skaar, Todd|Mukherjee, Pinku | ||||||||||
| PMID: | 18713982 | ||||||||||
| 3. | |||||||||||
| Journal: | Mol Cancer Ther. 2010 Feb;9(2):489-98. | ||||||||||
| Title: | Hydroxyamidine inhibitors of indoleamine-2,3-dioxygenase potently suppress systemic tryptophan catabolism and the growth of IDO-expressing tumors. | ||||||||||
| Author: | Koblish, Holly K|Hansbury, Michael J|Bowman, Kevin J|Yang, Gengjie|Neilan, Claire L|Haley, Patrick J|Burn, Timothy C|Waeltz, Paul|Sparks, Richard B|Yue, Eddy W|Combs, Andrew P|Scherle, Peggy A|Vaddi, Kris|Fridman, Jordan S | ||||||||||
| PMID: | 20124451 | ||||||||||
| 4. | |||||||||||
| Journal: | Pancreatology. 2010;10(5):631-40. | ||||||||||
| Title: | FOXP3+ regulatory T cells and tumoral indoleamine 2,3-dioxygenase expression predicts the carcinogenesis of intraductal papillary mucinous neoplasms of the pancreas. | ||||||||||
| Author: | Kobayashi, Noritoshi|Kubota, Kensuke|Kato, Shingo|Watanabe, Seitaro|Shimamura, Takeshi|Kirikoshi, Hiroyuki|Saito, Satoru|Ueda, Michio|Endo, Itaru|Inayama, Yoshiaki|Maeda, Shin|Nakajima, Atsushi | ||||||||||
| PMID: | 21051918 | ||||||||||
| 5. | |||||||||||
| Journal: | Cancer Res. 2011 Mar 15;71(6):2038-44. | ||||||||||
| Title: | Spontaneous cytotoxic T-Cell reactivity against indoleamine 2,3-dioxygenase-2. | ||||||||||
| Author: | Sorensen, Rikke Baek|Kollgaard, Tania|Andersen, Rikke Sick|van den Berg, Joost Huibert|Svane, Inge Marie|Straten, Per thor|Andersen, Mads Hald | ||||||||||
| PMID: | 21406395 | ||||||||||
| 6. | |||||||||||
| Journal: | Bioorg Med Chem Lett. 2012 Dec 15;22(24):7641-6. | ||||||||||
| Title: | Identification of selective inhibitors of indoleamine 2,3-dioxygenase 2. | ||||||||||
| Author: | Bakmiwewa, Supun M|Fatokun, Amos A|Tran, Anh|Payne, Richard J|Hunt, Nicholas H|Ball, Helen J | ||||||||||
| PMID: | 23122865 | ||||||||||
| 7. | |||||||||||
| Journal: | BMC Cancer. 2014 Oct 2;14:738. | ||||||||||
| Title: | Elevation of MMP-9 and IDO induced by pancreatic cancer cells mediates natural killer cell dysfunction. | ||||||||||
| Author: | Peng, Yun-Peng|Zhang, Jing-Jing|Liang, Wen-biao|Tu, Min|Lu, Zi-Peng|Wei, Ji-Shu|Jiang, Kui-Rong|Gao, Wen-Tao|Wu, Jun-Li|Xu, Ze-Kuan|Miao, Yi|Zhu, Yi | ||||||||||
| PMID: | 25274283 | ||||||||||
| 8. | |||||||||||
| Journal: | Cancer Immunol Res. 2015 Sep;3(9):1096-107. | ||||||||||
| Title: | Salmonella-Based Therapy Targeting Indoleamine 2,3-Dioxygenase Coupled with Enzymatic Depletion of Tumor Hyaluronan Induces Complete Regression of Aggressive Pancreatic Tumors. | ||||||||||
| Author: | Manuel, Edwin R|Chen, Jeremy|D'Apuzzo, Massimo|Lampa, Melanie G|Kaltcheva, Teodora I|Thompson, Curtis B|Ludwig, Thomas|Chung, Vincent|Diamond, Don J | ||||||||||
| PMID: | 26134178 | ||||||||||
| 9. | |||||||||||
| Journal: | Chin Med J (Engl). 2017 Mar 20;130(6):710-716. | ||||||||||
| Title: | Expression and Prognostic Value of Indoleamine 2,3-dioxygenase in Pancreatic Cancer. | ||||||||||
| Author: | Zhang, Tao|Tan, Xiang-Long|Xu, Yong|Wang, Zi-Zheng|Xiao, Chao-Hui|Liu, Rong | ||||||||||
| PMID: | 28303855 | ||||||||||
| 10. | |||||||||||
| Journal: | Int J Cancer. 2017 Aug 1;141(3):572-582. | ||||||||||
| Title: | Tumor cell expression of immune inhibitory molecules and tumor-infiltrating lymphocyte count predict cancer-specific survival in pancreatic and ampullary cancer. | ||||||||||
| Author: | Sideras, Kostandinos|Biermann, Katharina|Yap, Kevin|Mancham, Shanta|Boor, Patrick P C|Hansen, Bettina E|Stoop, Hans J A|Peppelenbosch, Maikel P|van Eijck, Casper H|Sleijfer, Stefan|Kwekkeboom, Jaap|Bruno, Marco J | ||||||||||
| PMID: | 28470686 | ||||||||||
| 11. | |||||||||||
| Journal: | Biochem J. 2017 Sep 28;474(20):3391-3402. | ||||||||||
| Title: | Carbidopa is an activator of aryl hydrocarbon receptor with potential for cancer therapy. | ||||||||||
| Author: | Ogura, Jiro|Miyauchi, Seiji|Shimono, Kazumi|Yang, Shengping|Gonchigar, Sathisha|Ganapathy, Vadivel|Bhutia, Yangzom D | ||||||||||
| PMID: | 28963435 | ||||||||||
| 12. | |||||||||||
| Journal: | Nat Commun. 2017 Nov 27;8(1):1811. | ||||||||||
| Title: | Nano-enabled pancreas cancer immunotherapy using immunogenic cell death and reversing immunosuppression. | ||||||||||
| Author: | Lu, Jianqin|Liu, Xiangsheng|Liao, Yu-Pei|Salazar, Felix|Sun, Bingbing|Jiang, Wen|Chang, Chong Hyun|Jiang, Jinhong|Wang, Xiang|Wu, Anna M|Meng, Huan|Nel, Andre E | ||||||||||
| PMID: | 29180759 | ||||||||||
| 13. | |||||||||||
| Journal: | Cancer Discov. 2018 Jul;8(7):OF5. | ||||||||||
| Title: | Companies Scaling Back IDO1 Inhibitor Trials. | ||||||||||
| Author: | |||||||||||
| PMID: | 29848606 | ||||||||||
| 14. | |||||||||||
| Journal: | Pathol Res Pract. 2018 Sep;214(9):1309-1314. | ||||||||||
| Title: | Indoleamine 2, 3-dioxygenase and B7-H1 expressions as prognostic and follow-up markers in human pancreatic carcinoma. | ||||||||||
| Author: | Wang, Liancai|Ma, Qingyong|Li, Deyu|Mu, Senmao|Li, Yong|Wang, Yafeng|Shi, Pengfei|Yu, Haibo|Gao, Chunhui|Guo, Kun|Zhang, Zhuoli | ||||||||||
| PMID: | 30029936 | ||||||||||